Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease.

Project Information

CARBALIVE

Grant agreement ID: 634579

DOI 10.3030/634579

Project closed

EC signature date 7 April 2015

Start date 1 May 2015

End date 31 January 2021

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 9 579 686,54

EU contribution € 5 913 079,75

Coordinated by

UNIVERSITY COLLEGE LONDON
United Kingdom

• Novel material for managing liver disease
  EN